Giant Cell (Temporal Arteritis)
Emeritus Research is proud to be running clinical trials to investigate whether new medicines can improve Giant Cell (Temporal Arteritis) for patients.
Emeritus’ leading Rheumatologists have been working with global pharmaceutical companies for the last 25 years, and have been part of research that developed many of today’s leading medicines.
Benefits of being involved in our clinical research include:
- No costs for the visits or medications.
- Payment for your time and travel
- Dedicated healthcare professionals who will work with you throughout the study
- Contributing to research that seeks to help other people living with chronic disease
Our past research was recently recognised by Channel 9 News:
Emeritus Research is a dedicated clinical trials site that will not be seeing any patients with coronavirus symptoms.
All patients will receive hospital-grade sanitiser upon arrival, and are escorted to a private consulting room for their visits – no waiting rooms. We want to ensure our patients can feel confident that they will receive treatment for their chronic disease during this challenging time.